10.85USD-3.64%Mkt Cap: 213.55M USDP/E: —Last update: 2026-06-01
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics to treat patients with disorders linked to dysfunctional signaling of the transforming growth factor-be…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap213.55M USD
Enterprise Value-42.53M USD
Revenue (TTM)33.18M USD
Gross Profit-61.35M USD
Net Income (TTM)87.01M USD
Revenue/Share1.037 USD
Last Price10.85 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees87
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.81
PEG—
EV/EBITDA0.40
EV/Revenue-1.28
P/S6.71
P/B0.78
EPS (TTM)-2.53
EPS (Forward)-6.22
52W Range
9.7908% of range22.55
52W High22.55 USD
52W Low9.790 USD
Profitability
Gross Margin-184.89%
Oper. Margin-7050.95%
EBITDA Margin0.00%
Profit Margin35.65%
ROE28.70%
ROA25.74%
Growth
Revenue Growth-99.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF107.50M USD
CapEx (TTM)1.55M USD
FCF Margin-113.58%
FCF Yield-17.65%
Net Debt-265.19M USD
Net Debt/EBITDA2.51
Balance Sheet
Debt/Equity0.06
Current Ratio22.61
Quick Ratio22.17
Book Value/Sh14.47 USD
Cash/Share14.22 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)21.83 USD
Target Range16.00 USD – 30.00 USD
# Analysts6
Ownership
Shares Out.19.79M
Float17.83M
Insiders3.65%
Institutions96.04%
Short Interest
Short Ratio5.4d
Short % Float9.91%
Short % Out.8.61%
Shares Short1.70M
Short (prev mo.)1.40M
Technical
SMA 5011.38 (-4.6%)
SMA 20015.30 (-29.1%)
Beta0.95
S&P 52W Chg27.94%
Avg Vol (30d)303.91K
Avg Vol (10d)416.09K
Technical Indicators
RSI (14)49.4
MACD-0.1336
MACD Signal-0.1870
MACD Hist.+0.0535
BB Upper12.49 USD
BB Middle11.30 USD
BB Lower10.11 USD
BB Width21.07%
ATR (14)0.6085 USD
Vol Ratio (20d)0.25x